Ubs Group Ag Aptorum Group LTD Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.42 - $11.7 $4,635 - $129,144	-11,038 Reduced 82.73%	2,305 $1,000
Q3 2022 Nov 10, 2022	BUY	$1.14 - $12.9 $7,557 - $85,514	6,629 Added 98.73%	13,343 $15,000
Q2 2022 Aug 10, 2022	BUY	$0.95 - $1.67 $4,454 - $7,830	4,689 Added 231.56%	6,714 $9,000
Q1 2022 May 16, 2022	BUY	$1.22 - $2.28 $2,470 - $4,617	2,025 New	2,025 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.5 - $2.64 $2,200 - $3,872	-1,467 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.39 - $3.22 $3,030 - $4,082	-1,268 Reduced 46.36%	1,467 $4,000
Q2 2021 Aug 13, 2021	BUY	$2.37 - $3.43 $1,583 - $2,291	668 Added 32.32%	2,735 $9,000
Q1 2021 May 12, 2021	SELL	$2.45 - $4.17 $12,088 - $20,574	-4,934 Reduced 70.48%	2,067 $6,000
Q4 2020 Feb 11, 2021	BUY	$2.03 - $2.89 $11,861 - $16,886	5,843 Added 504.58%	7,001 $17,000
Q3 2020 Nov 12, 2020	BUY	$1.22 - $4.76 $1,412 - $5,512	1,158 New	1,158 $3,000
Q2 2020 Jul 31, 2020	SELL	$2.81 - $4.7 $483 - $808	-172 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$2.06 - $16.0 $1,116 - $8,672	-542 Reduced 75.91%	172 $1,000
Q4 2019 Feb 14, 2020	SELL	$13.75 - $16.51 $11,137 - $13,373	-810 Reduced 53.15%	714 $11,000
Q3 2019 Nov 14, 2019	BUY	$15.0 - $24.49 $1,860 - $3,036	124 Added 8.86%	1,524 $25,000
Q2 2019 Aug 14, 2019	SELL	$13.3 - $32.55 $16,265 - $39,808	-1,223 Reduced 46.63%	1,400 $35,000
Q1 2019 May 14, 2019	BUY	$12.91 - $15.67 $14,859 - $18,036	1,151 Added 78.19%	2,623 $35,000
Q4 2018 Feb 14, 2019	BUY	$13.51 - $15.7 $19,886 - $23,110	1,472 New	1,472 $22,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $8.62M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.